Ten Procedures: China vs Your Country, Cost by Cost

If you're comparing the cost of a procedure across countries, what you usually want to know isn't which country is cheapest. It's something more specific: for the same procedure, how much does China differ from my own country, and is that gap big enough to be worth flying out for. This article lays out ten common procedures and compares their prices in the United States, the United Kingdom, Australia, Canada, Japan, South Korea, Singapore, Germany, France, and Russia against China, one procedure at a time, and explains where the gap comes from and what isn't counted.

What follows is a category price range tied to a point in time, not a quote for you personally. Anyone's actual cost depends on the tier of hospital, the choice of materials, and the complexity of the case, and the two ends of a range can differ several-fold. It also excludes emergencies; if you have an acute condition, seek care at the nearest facility. If what you want is a ranking of which country is cheapest, this article can't give you one, because the basis for prices varies enormously between countries: in some, residents pay nothing while foreign visitors pay the full amount; in others, the surgical fee is low but materials are billed separately. Laying out the basis for comparison is more useful than handing you a ranking. Below, we start with the ten-country master tables, then explain where the gap comes from and what isn't counted.

At a glance: cross-country prices for 10 procedures

The two tables below lay out the out-of-pocket price of ten procedures across ten countries. All figures are US dollar ranges, drawn from private or self-pay channels — that is, the price a foreign visitor without local insurance would actually face. Each procedure is priced on a different basis, marked in the procedure name; when comparing, always make sure you're looking at the same basis. China appears in both tables for easy reference.

China compared with the Americas, the United Kingdom, and Japan:

China compared with South Korea, Singapore, and continental Europe:

Two common misreadings worth clearing up first. First, a wide range doesn't mean prices are chaotic. The bottom of China's column is a public hospital's general clinic with domestic materials; the top is an international hospital with high-end imported materials; most foreign self-pay patients land in the middle. Read the range by working out which tier you'd actually use, rather than assuming you'll pay the maximum. Second, China isn't simply the cheapest. For dental implants, orthodontics, and LASIK, South Korea and China are roughly on a par, and Russia is even lower on several items; China's price advantage only really opens up on high-total-cost procedures like full-mouth implants, IVF, and knee replacement.

The UK's cataract and knee replacement prices carry a hidden layer too: for UK residents, both are covered by the NHS and free, with long waiting lists as the trade-off. The figures in the table are the UK's private self-pay prices — the amount a foreign visitor actually pays. The same goes for Australia and Canada. "Free" only holds for a country's own residents.

Why the gap is so large

When the same operation costs three to five times more in one country than another, the difference is mostly not about profit margins. It's the stacking of several structural costs.

Labor is the first. A large share of the surgical fee is the working hours of doctors, anesthetists, nurses, and technicians. A US orthopedic surgeon earns several times the annual income of a counterpart at a top-tier Chinese hospital, and that gap goes straight into the knee replacement bill. The more labor-intensive the surgery and the longer the hospital stay, the more this factor amplifies the difference.

Materials and equipment are the second. Implants, intraocular lenses, artificial joints — there are only a handful of global manufacturers, and factory prices don't differ much. But the markup on the way to the patient's bill varies enormously between countries. This is also the key to China's recent price drop, covered in the next section.

What the quote includes is the third factor — and the one most easily mis-compared. A Chinese public hospital's surgical fee looks low, but examinations, lab tests, imaging, and medications are often billed as separate line items; you have to add these up to get the full total. Conversely, a single operation in the US has three prices: the highest is the list price for those without insurance, the middle is the negotiated rate an insurer secures, and the lowest is the out-of-pocket amount an insured patient actually pays — but that only holds after premiums and the deductible have been met. Comparing China's bundled price directly with the US list price overstates the gap; comparing it with an insured US patient's out-of-pocket cost understates it. The tables use the foreign-visitor basis — the self-pay price without local insurance.

Finally, there's the structure of insurance and public systems. For procedures the UK, Canada, and Australia provide free to their own residents, the cost is shifted forward into taxes, and foreign visitors pay from a separate private price list. Japan, South Korea, Germany, and France reimburse their own insured residents a proportion of the cost, and foreign self-pay patients pay the full amount with reimbursement removed. Before saying a country is cheap, first ask: cheap for whom.

Centralized procurement: why China's prices dropped recently

If you checked China's dental implant or cataract prices a few years ago, today's figures are noticeably lower. The reason is a policy called nationally organized centralized volume-based procurement of drugs and medical consumables — centralized (bulk) procurement for short.

The mechanism is this: China's National Healthcare Security Administration (NHSA) bundles the demand of public hospitals nationwide and has materials manufacturers bid competitively, trading volume for price. The reductions have been steep. Artificial joints were brought into centralized procurement in 2021, and the price of imported knee prostheses fell from an average of over 30,000 yuan to around 7,000 yuan; dental implant materials went through centralized procurement in 2023, flattening the prices of domestic and mainstream imported implants; intraocular lenses for cataract surgery went through centralized procurement in 2024, pulling the high-end lenses that had been priced by brand into a similar range. This is the direct reason the lower end of China's prices for full-mouth implants, cataract, and knee replacement in the tables is noticeably depressed.

But centralized procurement hasn't flattened prices into a single number. It compresses the standard specifications within its coverage; the high-end models outside that scope aren't part of it, and their prices barely move. So for these procedures, China now has one end low and the other unchanged, which actually widens the range. One more thing to be clear about: centralized procurement prices directly benefit Chinese residents who use local public health insurance at public hospitals; foreign self-pay patients don't pay the insurance-settled price. But centralized procurement lowered the floor of the entire market, and the self-pay price of the public general-clinic tier came down with it — and that is the part a foreign visitor can benefit from.

The money saved isn't all net gain

The gap you see in the tables is the gross difference, not what you'll ultimately save. Flying out specifically for treatment carries several costs that aren't in the procedure quote, and you have to add them in yourself when comparing.

Round-trip airfare, accommodation, and a companion's expenses are the first. A trip abroad for treatment usually means staying in China for one to two weeks, and that alone can run to several thousand US dollars. The second is follow-up. Many procedures require post-operative checks, so you either extend your trip or, back home, find a local doctor to take over — and local doctors aren't always willing to take over someone else's work. The third is the risk of revision. If an implant fails, orthodontic results relapse, or a joint needs revision, dealing with these means flying out again, or accepting the hassle of switching doctors. The fourth is lost income.

Add these back in and the conclusion splits. For procedures with a low total cost to begin with — a single dental implant, one health checkup — the money saved may not even cover the airfare, and flying out specifically for it doesn't pay off. But for procedures where a single trip can save ten or twenty thousand US dollars, like full-mouth implants or IVF, travel costs are a small share, and the gap genuinely holds up. What decides whether it's worth it isn't the percentage saved, but whether the absolute amount saved clearly outweighs these hidden costs.

When it isn't worth flying out

Some procedures aren't suited to being done across borders, even when the price gap is large. The test isn't price; it's what you'll need after the operation.

Be cautious with surgery that requires months of local rehabilitation. Knee replacement requires three to six months of rehabilitation therapy afterward, and that has to continue where you normally live — it can't be done in China. Part of the money the surgery saved gets spent again on rehabilitation and follow-up back home, so the gap is discounted.

IVF has an additional legal threshold. China's assisted reproduction is legally available only to lawfully married heterosexual couples with an infertility diagnosis; single people, same-sex couples, and those who need donor eggs or surrogacy cannot legally receive it in China. And IVF often takes two or three cycles to succeed, so the single-cycle price in the table is not your true total budget. Comparing it as a one-off purchase will distort things badly.

Cases that need urgent treatment, or where post-operative complications are time-sensitive and must be followed up by the original surgeon, are also unsuited to medical travel. In these situations, the time and distance that cross-border care introduces are themselves a risk.

If your situation falls into any of the categories above, we recommend treating it locally first, however large the gap. This article can help you judge price; it can't judge your specific medical suitability.

How the data was compiled

Prices on the China side come from our field collection of quotes for the ten procedures, with 18 to 24 quotes from hospitals at different tiers cross-checked for each procedure, collected in May 2026. The median in China's column corresponds to the tier where foreign self-pay patients most often land — from a public hospital's general clinic to mid-range private — and excludes the high-end international hospital outliers.

Prices on the ten-country side come from cross-checking clinics' published quotes, industry association fee surveys, and public-system and insurance data; they reflect typical levels in private or self-pay channels, not a national average. Several Russian figures rest on thinner sources and have been treated as estimates. All prices were collected on each procedure's standard basis: dental implants per tooth, full-mouth implants per arch, cataract per eye, LASIK and ICL for both eyes, IVF per fresh cycle excluding donor eggs and genetic screening, knee replacement per knee, hair transplant per session of about 2,000 to 2,500 grafts, and health checkup per session. US dollar conversions are estimated at the mid-2026 exchange rate, roughly 7.2 RMB to 1 USD, for order-of-magnitude reference only.

Matching prices to your situation

The hardest part of cross-country price comparison isn't finding an individual figure — it's that the basis varies so much between countries: free for whom, before or after reimbursement, surgical fee with or without materials, priced per tooth or per arch. Aligning these bases and then applying them to the specific procedure you need takes someone familiar with the local system.

That alignment and application is exactly what WellChina does. We don't make medical judgments for you and don't recommend specific doctors, but we can help you choose the right tier of care, match the right institution and department, and verify the basis of a quote. Three service tiers correspond to three depths: a $29 self-check consultation, where we lay out your situation and check the tier and city choice; a $59 coordination service, helping you connect with institutions and confirm the department and quote; and full management from $129, covering booking, accompanied communication, and the handover after treatment.

If you already know which procedure you need and which city you're going to, you can contact a coordinator directly; if you're still in the comparison stage, first use the price tables above to see where your country stands on this procedure, then decide.

The price data in this article was cross-checked in May 2026. China-side prices come from WellChina's field collection of 18 to 24 hospital quotes for each of the ten procedures; the centralized procurement mechanism and timing reference China's National Healthcare Security Administration (NHSA) centralized procurement announcements over the years (artificial joints 2021, dental implant materials 2023, intraocular lenses 2024). Sources for other countries' prices include national dental and orthodontic association fee surveys, ophthalmology and reproductive medicine clinics' published quotes, public healthcare and insurance system data from each country, and medical cost comparison databases; US data references the ADA Health Policy Institute fee survey and AAO materials, the UK references NHS and private clinic pricing, Australia references the Medicare Medical Costs Finder, and Singapore references the Ministry of Health's fee benchmarks. Each country's figures are typical levels in private or self-pay channels, not a national average; some Russian items rest on thinner sources and are marked as estimates. US dollar conversions are estimated at the mid-2026 exchange rate, for order-of-magnitude reference only; the actual rate at the time prevails. Last reviewed May 2026; next review May 2027. — WellChina editorial team